SEI Investments’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.2M | Sell |
125,434
-4,770
| -4% | -$344K | 0.01% | 1134 |
|
|
2026
Q1 | $8.87M | Buy |
130,204
+38,115
| +41% | +$2.7M | 0.01% | 1199 |
|
|
2025
Q4 | $6.99M | Buy |
92,089
+33,748
| +58% | +$2.45M | 0.01% | 1225 |
|
|
2025
Q3 | $3.58M | Sell |
58,341
-10,727
| -16% | -$559K | ﹤0.01% | 1442 |
|
|
2025
Q2 | $3.37M | Buy |
69,068
+57,804
| +513% | +$2.74M | ﹤0.01% | 1430 |
|
|
2025
Q1 | $574K | Buy |
11,264
+5,990
| +114% | +$299K | ﹤0.01% | 2099 |
|
|
2024
Q4 | $238K | Buy |
+5,274
| New | +$226K | ﹤0.01% | 2430 |
|
|
2023
Q3 | – | Sell |
-40,591
| Closed | -$1.65M | – | 2681 |
|
|
2023
Q2 | $1.65M | Sell |
40,591
-2,388
| -6% | -$117K | ﹤0.01% | 1704 |
|
|
2023
Q1 | $2.08M | Buy |
42,979
+5,149
| +14% | +$235K | ﹤0.01% | 1599 |
|
|
2022
Q4 | $1.44M | Sell |
37,830
-1,131
| -3% | -$47K | ﹤0.01% | 1630 |
|
|
2022
Q3 | $1.96M | Sell |
38,961
-2,507
| -6% | -$123K | ﹤0.01% | 1555 |
|
|
2022
Q2 | $1.66M | Sell |
41,468
-3,470
| -8% | -$122K | ﹤0.01% | 1638 |
|
|
2022
Q1 | $1.68M | Buy |
44,938
+931
| +2% | +$35.9K | ﹤0.01% | 1607 |
|
|
2021
Q4 | $1.75M | Sell |
44,007
-209
| -0.5% | -$8K | ﹤0.01% | 1637 |
|
|
2021
Q3 | $1.65M | Sell |
44,216
-284
| -0.6% | -$11.7K | ﹤0.01% | 1587 |
|
|
2021
Q2 | $1.88M | Buy |
44,500
+8,500
| +24% | +$364K | ﹤0.01% | 1540 |
|
|
2021
Q1 | $1.71M | Sell |
36,000
-21,937
| -38% | -$1.3M | ﹤0.01% | 1520 |
|
|
2020
Q4 | $3.54M | Buy |
57,937
+571
| +1% | +$33.7K | 0.01% | 1117 |
|
|
2020
Q3 | $2.68M | Sell |
57,366
-29,583
| -34% | -$1.46M | 0.01% | 1159 |
|
|
2020
Q2 | $4.41M | Buy |
86,949
+21,862
| +34% | +$1.07M | 0.01% | 919 |
|
|
2020
Q1 | $2.9M | Buy |
65,087
+44,587
| +217% | +$2.24M | 0.01% | 991 |
|
|
2019
Q4 | $985K | Buy |
+20,500
| New | +$871K | ﹤0.01% | 1644 |
|
|
2019
Q2 | – | Sell |
-3,715
| Closed | -$140K | – | 2681 |
|
|
2019
Q1 | $140K | Sell |
3,715
-2,540
| -41% | -$85.3K | ﹤0.01% | 2405 |
|
|
2018
Q4 | $294K | Hold |
6,255
| – | – | ﹤0.01% | 1907 |
|
|
2018
Q3 | $294K | Buy |
6,255
+5,255
| +526% | +$217K | ﹤0.01% | 1813 |
|
|
2018
Q2 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 2629 |
|
|
2018
Q1 | $27K | Hold |
1,000
| – | – | ﹤0.01% | 2564 |
|
|
2017
Q4 | $17K | Sell |
1,000
-115
| -10% | -$1.95K | ﹤0.01% | 2655 |
|
|
2017
Q3 | $22K | Buy |
1,115
+115
| +12% | +$2.25K | ﹤0.01% | 2481 |
|
|
2017
Q2 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 2474 |
|
|
2017
Q1 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 2458 |
|
|
2016
Q4 | $11K | Sell |
1,000
-27,869
| -97% | -$292K | ﹤0.01% | 2458 |
|
|
2016
Q3 | $404K | Sell |
28,869
-212
| -0.7% | -$1.72K | ﹤0.01% | 1503 |
|
|
2016
Q2 | $204K | Buy |
29,081
+11,741
| +68% | +$86.1K | ﹤0.01% | 1550 |
|
|
2016
Q1 | $111K | Sell |
17,340
-23,669
| -58% | -$411K | ﹤0.01% | 1654 |
|
|
2015
Q4 | $1.33M | Sell |
41,009
-17,465
| -30% | -$514K | 0.01% | 1135 |
|
|
2015
Q3 | $1.56M | Buy |
58,474
+8,106
| +16% | +$347K | 0.01% | 890 |
|
|
2015
Q2 | $2.42M | Buy |
50,368
+25,252
| +101% | +$1.47M | 0.02% | 681 |
|
|
2015
Q1 | $1.53M | Buy |
+25,116
| New | +$1.53M | 0.01% | 826 |
|
Other funds holding PTCT
RI
JT
SEI Investments's PTCT Position: Q2 2026 in Review
SEI Investments reduced its PTC Therapeutics (PTCT) stake by 3.7% in Q2 2026, selling an estimated $344K and leaving 125,434 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #1134.
SEI Investments first reported a position in PTCT in Q1 2015 and has held it in 39 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- SEI Investments held 125,434 shares of PTC Therapeutics worth $10.2M as of Q2 2026.
- SEI Investments sold 4,770 PTC Therapeutics shares in Q2 2026, an estimated $344K.
- PTC Therapeutics made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1134 holding.
- SEI Investments first reported a position in PTC Therapeutics in Q1 2015 and has held it in 39 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.